Recent Updates
Recently added Catalysts
NVCR Positive Sentiment

Novocure to Report Third Quarter 2026 Financial Results

Thursday, October 1, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Novocure is set to announce its financial results for the third quarter of 2026 on October 29, 2026. The report will be released before the U.S. markets open, followed by a conference call at 8:00 a.m. EDT to discuss the results. This event highlights the company's commitment to keeping stakeholders informed.

Market Sentiment Analysis

POSITIVE FACTORS

  • Novocure will report its financial results, indicating ongoing operations.
  • The scheduled conference call shows transparency and engagement with investors.

Full Press Release Details

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (Nasdaq: NVCR) will report financial results for the third quarter 2026 on October 29, 2026, before the U.S. financial markets open. Novocure management will host a conference call and webcast at 8:00 a.m. EDT, October 29, to discuss the company’s financial results for the three-month period that ended September 30, 2026. To access the conference call by phone, use the following conference call registration link and dial-in details will be provided.

Frequently Asked Questions

When will Novocure report its Q3 2026 financial results?

Novocure will report its Q3 2026 financial results on October 29, 2026.

What time is the Novocure conference call?

The conference call will take place at 8:00 a.m. EDT on October 29, 2026.

How can I access the Novocure conference call?

Access details for the Novocure conference call will be provided via a registration link.

ShareAdd on Google
Tags: NVCR Novocure financial results Q3 2026 conference call investor relations
Last updated: Oct 1, 2026

Biotech snapshot

Cash runway
$441M liquidity · $0M/mo burn
Low dilution risk
Lead asset
Immune checkpoint inhibitors or docetaxelPhase 3
Nonsmall Cell Lung Cancer →